Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.
Press releases published on September 23, 2025
ONYC® Hair Launches Sleek Relaxed: Premium Double Drawn Vietnamese Hair for a True Silk Press Finish
The new Sleek Relaxed Collection delivers unmatched fullness, silk press sleekness, and long-lasting versatility. ROCKVILLE, MD, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- ONYC® Hair, a global leader in luxury hair extensions, proudly …
FR Conversions Achieves Ford Pro Upfitter Accreditation
Company earns FPU status for its Type II ambulances and full-size van mobility solutions WESTMINSTER, MD, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- FR Conversions, a national leader in emergency and mobility vehicle innovation, has earned …
Fasoo Named Finalist for Best AI Integration at the 2025 A.I. Awards with Wrapsody and Ellm
BETHESDA , MD, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Fasoo, the leader in data-centric security, today announced that its AI enterprise LLM and AI data infrastructure solutions, Ellm and Wrapsody, have been named a finalist in the Best …
Emerald Intel Launches New Dataset, Providing Users with In-Depth Profiles on Cannabis Related Businesses
Leading Cannabis Industry Data Provider Now Profiles Ancillary Businesses, Including Cannabis Brand Houses and Vendors BETHESDA, MD, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Emerald Intel, the leading provider of cannabis market …
EB5 Capital Celebrates the Closing of Atlanta Woodrow Apartments (JF41)
WASHINGTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EB5 Capital is pleased to announce the closing of its $42.4 million investment in Woodfield Development’s Atlanta Woodrow Apartments (JF41) project. Located in Atlanta, Georgia, the high-unemployment Target …
GL Strengthens Mobile Network Testing with Location and Fallback Solutions
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- GL Communications Inc., a global leader in telecom testing solutions, addressed the press regarding their protocol emulation suite, Message Automation and Protocol Simulation (MAPS™), supporting …
Stacey Osborn, Champion Petfoods Global President and Visionary Leader, Joins National 4-H Council Board of Trustees
WASHINGTON, D.C., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Stacey Osborn, Global President of Champion Petfoods, joins the National 4-H Council Board of Trustees. With a talent for bringing clear focus to rapidly evolving businesses and expanding capabilities, …
H.H.C. Group Launches “Proof in the Pudding” Savings Program for Prospective Client TPAs, Stop-Loss and Self-Insured Payors
ROCKVILLE, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment solutions, proudly announces the launch of its new “Proof in the Pudding” savings program — a no-risk …
Jason Henshaw Named Vice President and General Manager of Perdue Specialty Meats
Westminster, Colo., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Perdue Specialty Meats and Emerging Brands today announced the appointment of Jason Henshaw as Vice President and General Manager of Perdue Specialty Meats, which includes the premium and natural …
BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the …
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
BETHESDA, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric, small-molecule therapies …
Altimmune to Participate in Two Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the …